Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2017-03-15
2018-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
IL-6, IL-17 and IL-35 Levels in the Gingival Crevicular Fluid of Patients With Periodontitis and Healthy Controls
NCT05306860
Analysis of Gingival Crevicular Fluid
NCT05325905
Evaluation of Salivary Biomarker Levels in Individuals With Different Periodontal Conditions
NCT06558136
Effect of Non-Surgical Periodontal Treatment on Gingival Crevicular Fluid and Serum Biomarker Levels
NCT06175624
GCF Galectin-3 and Interleukin-1beta Levels in Periodontitis.
NCT05449093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1. Healthy individuals from periodontal perspective:
GI \< 1, PD ≤ 3 mm, CAL = 0 mm, with no apparent bone loss on radiography.
Biomarker test
Diagnostic biomarker study
Group 2. Individuals diagnosed with Gingivitis
GI \> 1, PD ≤ 3 mm, CAL = 0 mm, with no apparent bone loss on radiography.
Biomarker test
Diagnostic biomarker study
Group 3. Individuals diagnosed with CP
GI \> 1, PD ≥ 5 mm, CAL ≥ 3 mm, with apparent bone loss on radiography.
Biomarker test
Diagnostic biomarker study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biomarker test
Diagnostic biomarker study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
32 Years
52 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bulent Ecevit University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ÇİĞDEM COŞKUN TÜRER
clinical associate professor, DDS, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Çiğdem Coşkun Türer
Zonguldak, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
hepcidin
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.